JPRN-UMIN000035712
Recruiting
未知
Bladder cancer prospective cohort study on high-risk non-muscle invasive cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor(BRIGHT study) - BRIGHT study
Yamaguchi University Graduate School of Medicine0 sites200 target enrollmentFebruary 1, 2019
Conditionsnon-muscle invasive bladder cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- non-muscle invasive bladder cancer
- Sponsor
- Yamaguchi University Graduate School of Medicine
- Enrollment
- 200
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Patients with incomplete resection on first PDD\-TUR 2\)Patients with pT2 or Extensive CIS 3\)Patients with previously enrolled in this study 4\)Patients determined to be ineligible for this clinical study by research attending physician
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
BRAVO Study: Surgery vs. Immunotherapy – Which treatment is best in bladder cancer?Specialty: Cancer, Primary sub-specialty: BladderUKCRC code/ Disease: Cancer/ Malignant neoplasms of urinary tractCancerBladder cancerISRCTN12509361Sheffield Teaching Hospitals NHS Foundation Trust50
Active, not recruiting
Phase 1
ORTH-REG Dwell-Time Studyrothelial cancerTherapeutic area: Diseases [C] - Male Urogenital Diseases [C12]Therapeutic area: Diseases [C] - Female Urogenital Diseases and Pregnancy Complications [C13]CTIS2023-505936-37-00Aarhus University Hospital101
Active, not recruiting
Phase 1
ordic Urothelial Cancer Research Group Study on Reduced BCG Dwell-Time in High Risk NMIBC Short title: NORTH-REG Dwell-Time StudyEUCTR2020-003112-27-DKAarhus University314
Active, not recruiting
Phase 1
ordic Urothelial Cancer Research Group Study on Reduced BCG Dwell-Time in High Risk NMIBC Short title: NORTH-REG Dwell-Time StudyReduced BCG dwell time in patients who are diagnosed with high risk non-muscle-invasive- bladder cancerMedDRA version: 20.0Level: LLTClassification code 10005004Term: Bladder cancer NOSSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2020-003112-27-SEAarhus University314
Not yet recruiting
Phase 3
The Global randomized NBi bladder cancer study A Multi-Centre, International study to compare the use of Narrow Band Imaging (NBI) versus White light (WL) to assess recurrence of bladder cancer in terms of safety and efficacy.NL-OMON34696Academisch Medisch Centrum20